Multi-modular Chimeric Antigen Receptor T Cells tarGeting B7-H3 in Children, Teenage & Young Adult Sarcoma

NCT07751380 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma

Interventions

DRUG: Biological/Vaccine: hBRCA84D CAR T cells

Sponsor

University College, London